[HIV infections].
Teruya
Katsuji
K
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D018562:Disease Transmission, Infectious; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology* / Q000635:transmission; D006526:Hepatitis C / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D018445:Infectious Disease Transmission, Vertical; D007372:Interferons / Q000008:administration & dosage / Q000009:adverse effects; D010349:Patient Compliance; D012254:Ribavirin / Q000008:administration & dosage / Q000009:adverse effects; D017211:Treatment Failure
D019380:Anti-HIV Agents; D012254:Ribavirin; D007372:Interferons